Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

Seth Hetherington, Sue McGuirk, Gwendolyn Powell, Amy Cutrell, Odin Naderer, Bill Spreen, Steve Lafon, Gill Pearce, Helen Steel

Open source

DOI
10.1016/s0149-2918(01)80132-6
Published
2001-10
Container
Clinical Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0149-2918-01-80132-6,
  title = {Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir},
  author = {Seth Hetherington and Sue McGuirk and Gwendolyn Powell and Amy Cutrell and Odin Naderer and Bill Spreen and Steve Lafon and Gill Pearce and Helen Steel},
  year = {2001},
  journal = {Clinical Therapeutics},
  doi = {10.1016/s0149-2918(01)80132-6},
  url = {https://doi.org/10.1016/s0149-2918(01)80132-6}
}

RIS

TY  - JOUR
TI  - Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
AU  - Seth Hetherington
AU  - Sue McGuirk
AU  - Gwendolyn Powell
AU  - Amy Cutrell
AU  - Odin Naderer
AU  - Bill Spreen
AU  - Steve Lafon
AU  - Gill Pearce
AU  - Helen Steel
PY  - 2001
JO  - Clinical Therapeutics
DO  - 10.1016/s0149-2918(01)80132-6
UR  - https://doi.org/10.1016/s0149-2918(01)80132-6
ER  - 

APA

Hetherington, S., McGuirk, S., Powell, G., Cutrell, A., Naderer, O., Spreen, B., Lafon, S., Pearce, G., & Steel, H. (2001). Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(01)80132-6

Source records